This study looked at continuous subcutaneous insulin infusions (CSII) for the treatment of diabetic retinopathy (DR; eye disease). It found that compared to multiple daily injections of insulin (MDI), CSII resulted in a less worsening of DR.

This study compared mecobalamin (vitamin B12) injections with mecobalamin tablets for the treatment of diabetic peripheral neuropathy (DPN; nerve damage). It showed that after 8 weeks of treatment, patients treated with mecobalamin injections showed signs of nerves being repaired, while no effects were seen in those taking the tablets.  

This study looked at tirzepatide, a new treatment for type 2 diabetes, compared to semaglutide (Ozempic).  It found that, depending on the dose, tirzepatide was similarly or more effective at controlling blood glucose than semaglutide. 

This review looked at whether antioxidant supplements can reduce inflammation for women with diabetes during pregnancy (gestational diabetes; GDM). It found that supplements including omega-3, vitamin D, and magnesium reduced oxidation in the body for these women.

This review looked at whether bariatric (weight-loss) surgery (BS) improves life expectancy for adults with or without type 2 diabetes (T2D). It found that BS improved life expectancy for people with diabetes by 9.3 years.

This study looked at the use of piperazine ferulate (PF) in diabetic patients. It found that adding PF to angiotensin receptor blocker (ARB) treatment helped to protect kidney function in patients with diabetes.

This long-term study looked at mental sharpness and coordination as adults age with type 1 diabetes (T1D). It found that blood sugar control over the previous 30 years influences later coordination and memory.

This study compared two methods of continuous glucose monitoring (CGM) for patients with type 1 diabetes (T1D). It found that compared to intermittent monitoring, real-time monitoring led to better glucose control and reduced risk of severe hypoglycemia.

This study looked at the use of citicoline and vitamin B12 eye drops (OMK2) to prevent diabetic retinopathy (DR; eye disease) in patients with type 1 diabetes (T1D). It found that using these drops for 36 months improved eye function tests. 

This study looked at the relationship between changes in the retinal nerves (diabetic retinopathy; DR) and changes in the nerves of the hands and feet (diabetic neuropathy; DN) in adolescents with type 1 diabetes (T1D). It found that tests that monitor the retinal nerves such as OCTA which is a quick and inexpensive test, could be used to identify patients with DN who need further nerve investigations.